Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 27 July 650x100px
Person › Details

Piet Wigerinck (Galapagos N.V. (Euronext + Nasdaq: GLPG))

Wigerinck, Piet (Galapagos 201304 CSO before SVP Developm before Tibotec)

 

Organisations Organisation Galapagos N.V. (Euronext + Nasdaq: GLPG)
  Group Galapagos (Group)
  Former/major organisation Tibotec Therapeutics (division of Ortho Biotech Products L.P.)
  Group Johnson & Johnson (JnJ) (Group)
Products Product drug discovery
  Product 2 drug discovery services
     

   
Record changed: 2020-08-19

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px


More documents for Piet Wigerinck


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x300px




» top